Learn about our upcoming and previous conferences
Download the entire program as a word document Choose a Day1 - 2 - 3 - 4
7:00-8:00
Breakfast
8:00 AM
Dr. Pilarski (Canada)
Origin of the malignant clone in WM
8:15 AM
Dr. Sahota (UK)
Identifying the WM malignant clone
8:30 AM
Dr. Ocio (Spain)*
Cytogenetics and cell cycle analysis in WM
8:45 AM
Dr. Shaughnessy (USA)
Genomic characterization of WM
9:00 AM
Dr. Fonseca (USA)
Special Lecture: "Genetic basis of WM"
9:30 AM
Dr. Tournilhac (France)
Role of mast cells in WM pathogenesis
9:45 AM
Dr. Santos (Brazil)*
Mast cell-tumor cell interactions in WM
10:00-10:30
Wrap-Up and Discussion
10:30-11:00
Session Break
Refreshments
11:00 AM
Dr. Dammacco (Italy)
Hepatitis C predisposition to WM
11:15 AM
Dr. Adamia (Canada)*
Aberrant gene splicing and genetic predispositions in WM
11:30 AM
R. Manning/Z. Hunter (USA)
Genetic Predisposition in WM
11:45 AM
Dr. McMaster (USA)
Long-Term Follow-up on WM Kindred
12:00-12:30
12:45-2:00
Lunch
2:00 PM
Dr. Berger (France)
Clinicopathological features of WM and MZL
2:15 PM
Dr. Pangalis (Greece)
Differential diagnosis of WM and other B-cell disorders
2:30 PM
Dr. Remstein (USA)
Characteristics of LPC vs. non-LPC disorders
2:45 PM
Dr. San Miguel (Spain)
Immunophenotypic and cytogenetic comparison of WM and MZL
3:00-3:30
3:30-3:45
3:45 PM
Dr. Kyle (USA)
Prognostic factors predicting evolution of IgM MGUS
4:00 PM
Dr. Nichols (USA)
Presenting features of IgM MGUS
4:15 PM
Dr. Cesana (Italy)*
Clinical characteristics and outcome of IgM related disorders
4:30 PM
Dr. Morra (Italy)
Prognostic factors for transformation in IgM MGUS
4:30-5:00
*Young Investigator Award Recipient; Sponsored by the International Waldenstrom's Macroglobulinemia Foundation.
Contact us | Site Map | Workshop News